XML 94 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Grant Agreements - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Aug. 31, 2017
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Nov. 05, 2021
Jan. 01, 2021
Feb. 29, 2020
Mar. 16, 2018
Jan. 26, 2018
Grant Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue from grants   $ 8,347,000 $ 9,123,000 $ 7,380,000          
Bill & Melinda Gates Foundation | Grant Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue from grants       900,000          
National Institutes of Health                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant awarded amount   5,100,000              
National Institutes of Health | Grant Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue from grants   $ 100,000 600,000 900,000          
2017 Grant | Bill & Melinda Gates Foundation                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant agreement expiration date May 31, 2019                
2017 Grant | Bill & Melinda Gates Foundation | Maximum                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant awarded amount $ 4,700,000                
Human Immunodeficiency Virus ("HIV") Grant                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant awarded amount             $ 8,600,000    
Grant agreement expiration date before amendment   Dec. 31, 2021              
Grant agreement amended expiration date   Oct. 31, 2022              
Grants Agreement Amended Date   2021-06              
Human Immunodeficiency Virus ("HIV") Grant | Maximum                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant awarded amount. maximum                 $ 12,200,000
Human Immunodeficiency Virus ("HIV") Grant | Bill & Melinda Gates Foundation                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue   $ 2,300,000 3,800,000            
Human Immunodeficiency Virus ("HIV") Grant | Bill & Melinda Gates Foundation | Grant Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue from grants     6,400,000 3,700,000          
Milestone payment due to Vir     1,900,000            
Milestone payment received           $ 1,900,000      
Tuberculosis ("TB") Grant                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant agreement amended expiration date   Mar. 31, 2022              
Unused funds received in advance   $ 1,800,000              
Tuberculosis ("TB") Grant | Grant Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue from grants   3,000,000.0 2,200,000 $ 1,900,000          
Tuberculosis ("TB") Grant | Maximum                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant awarded amount. maximum               $ 14,900,000  
Tuberculosis ("TB") Grant | Bill & Melinda Gates Foundation                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue   $ 1,300,000 $ 2,600,000            
HCMV-Vaccine Platform Grant                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant agreement expiration date   Aug. 30, 2023              
Deferred revenue   $ 3,300,000              
HCMV-Vaccine Platform Grant | Grant Member                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue from grants   $ 2,200,000              
HCMV-Vaccine Platform Grant | Maximum                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grant awarded amount. maximum         $ 10,000,000.0